SEEL

Seelos Therapeutics, Inc.

0.80 USD
-0.03 (-3.74%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Seelos Therapeutics, Inc. stock is down -26.2% since 30 days ago. The next earnings date is Mar 8, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 35.71% of the previous 28 February’s closed higher than January.

About Seelos Therapeutics, Inc.

Seelos Therapeutics, Inc. focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the. treatment of acute suicidal ideation and behavior in patients with major depressive disorders.